# Exzeo Group, Inc.: overview XZO · NYSE · CIK 1873951 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/xzo.md) · [Financials](/companies/xzo/financials.md) · [Filings](/companies/xzo/filings.md) · [Insiders](/companies/xzo/insiders.md) Latest reported revenue: [$57.8m](/filings/0001193125-26-340267.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-340267). ## Last eight quarters | Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [29.1](/filings/0001193125-25-315970.md) | [44.5 d](/filings/0001193125-26-076686.md) | [52.4](/filings/0001193125-26-211961.md) | [56.1](/filings/0001193125-26-340267.md) | [55.2](/filings/0001193125-25-315970.md) | [53.3 d](/filings/0001193125-26-076686.md) | [55.5](/filings/0001193125-26-211961.md) | [57.8](/filings/0001193125-26-340267.md) | | Gross margin | % | [38.2%](/filings/0001193125-25-315970.md) | [42.0% d](/filings/0001193125-26-076686.md) | [55.0%](/filings/0001193125-26-211961.md) | [59.8%](/filings/0001193125-26-340267.md) | [61.2%](/filings/0001193125-25-315970.md) | [65.4% d](/filings/0001193125-26-076686.md) | [59.0%](/filings/0001193125-26-211961.md) | [63.7%](/filings/0001193125-26-340267.md) | | Operating margin | % | [23.1%](/filings/0001193125-25-315970.md) | [35.0% d](/filings/0001193125-26-076686.md) | [45.4%](/filings/0001193125-26-211961.md) | [50.1%](/filings/0001193125-26-340267.md) | [49.4%](/filings/0001193125-25-315970.md) | [50.3% d](/filings/0001193125-26-076686.md) | [45.2%](/filings/0001193125-26-211961.md) | [49.3%](/filings/0001193125-26-340267.md) | | Net margin | % | [18.1%](/filings/0001193125-25-315970.md) | [26.3% d](/filings/0001193125-26-076686.md) | [34.3%](/filings/0001193125-26-211961.md) | [38.6%](/filings/0001193125-26-340267.md) | [38.3%](/filings/0001193125-25-315970.md) | [41.2% d](/filings/0001193125-26-076686.md) | [36.7%](/filings/0001193125-26-211961.md) | [40.3%](/filings/0001193125-26-340267.md) | | Diluted EPS | $ per share | [0.06](/filings/0001193125-25-315970.md) | not reported | [0.22](/filings/0001193125-26-211961.md) | [0.26](/filings/0001193125-26-340267.md) | [0.25](/filings/0001193125-25-315970.md) | not reported | [0.22](/filings/0001193125-26-211961.md) | [0.26](/filings/0001193125-26-340267.md) | | Free cash flow | $m | not reported | [19.3 d](/filings/0001193125-26-076686.md) | [19.0](/filings/0001193125-26-211961.md) | [37.3 d](/filings/0001193125-26-340267.md) | [30.3 d](/filings/0001193125-25-315970.md) | [10.9 d](/filings/0001193125-26-076686.md) | [25.1](/filings/0001193125-26-211961.md) | [15.2 d](/filings/0001193125-26-340267.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets; Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure. ## Last five fiscal years | Line item | Unit | FY (2023-12-31) | FY (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | | Revenue | $m | [88.3](/filings/0001193125-26-076686.md) | [134](/filings/0001193125-26-076686.md) | [217](/filings/0001193125-26-076686.md) | | Gross margin | % | [19.6%](/filings/0001193125-26-076686.md) | [39.7%](/filings/0001193125-26-076686.md) | [60.4%](/filings/0001193125-26-076686.md) | | Operating margin | % | [2.9%](/filings/0001193125-26-076686.md) | [28.4%](/filings/0001193125-26-076686.md) | [48.8%](/filings/0001193125-26-076686.md) | | Net margin | % | [24.3%](/filings/0001193125-26-076686.md) | [33.8%](/filings/0001193125-26-076686.md) | [38.1%](/filings/0001193125-26-076686.md) | | Diluted EPS | $ per share | [0.15](/filings/0001193125-26-076686.md) | [0.44](/filings/0001193125-26-076686.md) | [0.99](/filings/0001193125-26-076686.md) | | Free cash flow | $m | [6.9](/filings/0001193125-26-076686.md) | [45.9](/filings/0001193125-26-076686.md) | [97.5](/filings/0001193125-26-076686.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/xzo/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Jupiter Topco LLC](/funds/2146052.md) | 2026-06-30 | $12.3m | 728,237 | | Not compared | | [JANUS HENDERSON GROUP PLC](/funds/1274173.md) | 2026-03-31 | $10.3m | 703,304 | | Not compared | | [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $10.2m | 602,830 | | New +602,830 | | [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $9.6m | 571,335 | | Reduced −32,938 | | [JENNISON ASSOCIATES LLC](/funds/53417.md) | 2026-06-30 | $9.6m | 568,680 | | Reduced −6,237 | | [Whetstone Capital Advisors, LLC](/funds/1607278.md) | 2026-06-30 | $9.1m | 541,544 | | Added +130,191 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $7.7m | 457,881 | | Added +183,171 | | [ESSEX INVESTMENT MANAGEMENT CO LLC](/funds/201772.md) | 2026-06-30 | $4.5m | 268,704 | | Reduced −19,407 | | [FJ Capital Management LLC](/funds/1599170.md) | 2026-06-30 | $3.8m | 223,788 | | Reduced −458,652 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $2.9m | 172,700 | | Added +58,952 | ## Recent filings [All 106 filings](/companies/xzo/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-14 | 16:29 ET | [8-K](/filings/0001193125-26-352384.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-352384 | | 2026-08-07 | 16:14 ET | [10-Q](/filings/0001193125-26-340267.md) | Quarterly report, period 2026-06-30 | 0001193125-26-340267 | | 2026-08-06 | 16:19 ET | [8-K](/filings/0001193125-26-338098.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-338098 | | 2026-06-10 | 16:15 ET | [8-K](/filings/0001193125-26-265863.md) | 5.07 Shareholder vote results | 0001193125-26-265863 | | 2026-05-26 | 16:17 ET | [8-K](/filings/0001193125-26-239353.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-239353 | | 2026-05-15 | 16:33 ET | [10-Q/A](/filings/0001193125-26-226982.md) | Quarterly report, amended, period 2026-03-31 | 0001193125-26-226982 | | 2026-05-07 | 16:16 ET | [10-Q](/filings/0001193125-26-211961.md) | Quarterly report, period 2026-03-31 | 0001193125-26-211961 | | 2026-05-06 | 16:20 ET | [8-K](/filings/0001193125-26-209055.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-209055 | | 2026-04-29 | 16:17 ET | [DEF 14A](/filings/0001193125-26-191689.md) | Proxy statement, period 2026-06-09 | 0001193125-26-191689 | | 2026-02-26 | 16:14 ET | [10-K](/filings/0001193125-26-076686.md) | Annual report, period 2025-12-31 | 0001193125-26-076686 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-076686.md), filed Feb 26, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/57a6027b-a7ec-4e88-be9a-8c2f17e5b435) ## About the filer - CIK: 1873951 - Tickers: XZO - Exchange: NYSE - SIC code: 7372 Services-Prepackaged Software - State of incorporation: FL - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.